Published in Hepatitis Weekly, March 12th, 2001
In July 1999, the recommendations for routine vaccination of newborns against hepatitis B were temporarily changed because of concerns about the vaccine preservative thimerosal. No harm from thimerosal had been demonstrated, and hepatitis B vaccines without preservatives were available by September 1999.
However, analysis of data from immunization registries in Oregon and Oklahoma, and from a survey of hospitals in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.